Ghana has officially received its first batch of Human Papillomavirus (HPV) vaccines—a major milestone in efforts to curb cervical cancer across the country.
The shipment, which brought in 441,860 doses, marks the beginning of a wide-reaching vaccination campaign aimed at protecting young girls from one of the most preventable yet deadly diseases affecting women.
In the coming weeks, over 2.5 million doses will be delivered to Ghana through UNICEF, the organization overseeing the vaccine’s procurement and distribution.
According to a statement from UNICEF, these vaccines will support a five-day national campaign scheduled for September 2025, led by the Ghana Health Service (GHS). Following this initiative, the HPV vaccine will become part of Ghana’s routine immunization program—offered free to girls aged nine.
This step places Ghana among more than 140 countries that have already included the HPV vaccine in their public health strategies.
Cervical cancer, often caused by persistent infection with high-risk HPV strains, is largely preventable. Yet, in many low- and middle-income countries, early detection and access to vaccines remain limited due to low awareness, cost, and healthcare barriers.
UNICEF’s statement highlighted the urgent need for action: “Though cervical cancer is one of the most preventable female cancers, lack of information, limited access to preventive care, and affordability continue to be major roadblocks. Including the HPV vaccine in the national immunization schedule is a meaningful step forward.”
Introducing this vaccine into the country’s Expanded Programme on Immunization (EPI) is expected to significantly reduce cervical cancer cases in the future, offering protection and hope to countless girls.
“Preventing cervical cancer gives girls a chance to thrive, grow into strong women, and contribute to their families and communities,” the statement concluded.
